Results 111 to 120 of about 3,306,611 (204)

New‐Onset Type 2 Diabetes Mellitus and Cancer Risk: A Matched Cohort Study in China Kadoorie Biobank

open access: yesInternational Journal of Cancer, Volume 159, Issue 11, Page 2705-2719, 1 December 2026.
ABSTRACT The prevalence of type 2 diabetes mellitus (T2DM) is rising rapidly in China and is linked to increased cancer risk, but causality remains unclear due to biases. We examined the causal effect of T2DM on cancer risk using bias‐minimizing methods.
Mengying Wang   +9 more
wiley   +1 more source

Implications of the index cholecystectomy and timing of referral for radical resection of advanced incidental gallbladder cancer

open access: yes, 2015
INTRODUCTION Advanced (pT2/T3) incidental gallbladder cancer is often deemed unresectable after restaging. This study assesses the impact of the primary operation, tumour characteristics and timing of management on re-resection. METHODS The records of 60
Ausania F   +6 more
core   +1 more source

Comparative incidence of incidental gallbladder cancer in emergency cholecystectomies versus in elective cholecystectomies.

open access: yes, 2019
Objective: to comparatively analyse the incidence of incidental gallbladder cancer in emergency cholecystectomies versus in elective cholecystectomies performed in public hospitals in Teresina city, Piaui state (PI).
Marlon Moreno da Rocha Caminha de Paula (8401962)   +2 more
core   +1 more source

Effectiveness of Adding GLP‐1 Receptor Agonists to SGLT2 Inhibitor Therapy in Chronic Kidney Disease: A Population Based Study

open access: yesDiabetes, Obesity and Metabolism, Volume 28, Issue 12, Page 11755-11764, December 2026.
ABSTRACT Background Individually, sodium–glucose co‐transporter‐2 inhibitors (SGLT2i) and glucagon‐like peptide‐1 receptor agonists (GLP‐1RAs) have been shown to reduce major kidney and cardiovascular events in patients with chronic kidney disease (CKD). However, evidence supporting combined GLP‐1RA and SGLT2i therapy in this population remains limited.
Hussain Salim   +9 more
wiley   +1 more source

The Circulating Cholangiocarcinoma Protein Biomarkers CRP and MASP2 Also Predict Gallbladder Cancer Risk

open access: yesInternational Journal of Cancer, Volume 159, Issue 10, Page 2403-2407, 15 November 2026.
ABSTRACT In a recent publication, Lapitz et al. reported differences in serum levels that predict the development of cholangiocarcinoma (CCA) in patients with primary sclerosing cholangitis prior to clinical manifestation. We examined whether these biomarkers also predict the risk of gallbladder cancer (GBC) in European prospective plasma samples from ...
Linda Zollner   +4 more
wiley   +1 more source

Fibronectin in human gallbladder bile: cholesterol pronucleating and/or mucin "link" protein? [PDF]

open access: yes, 1994
Some biliary proteins (pronucleators) seem to be essential factors for cholesterol crystal formation and crystal growth in bile. A recent study suggests that fibronectin is such a pronucleator in bile.
Ritter, Christoph von   +11 more
core   +1 more source

Real‐World Validation of the MAGIC‐D Index in Unresectable Biliary Tract Cancer Treated With Durvalumab Plus Chemotherapy

open access: yesCancer Medicine, Volume 15, Issue 11, November 2026.
Real‐world Validation of the MAGIC‐D Index. The MAGIC‐D index was validated using real‐world data from patients with unresectable BTC who received durvalumab‐chemotherapy at Tongji Hospital. The risk stratification ability of the MAGIC‐D index for patient survival was improved after incorporating Ki67 and CA 19‐9.
Tianao Zhan   +9 more
wiley   +1 more source

A Rare Hepatoblastoma in a 10‐Year‐Old Boy Presenting With Tumor Rupture and Normal Alpha‐Fetoprotein Levels: A Case Report

open access: yesClinical Case Reports, Volume 14, Issue 11, November 2026.
A 10‐year‐old boy presented with a large hepatic mass (12.0 × 11.6 × 10.6 cm), classified as PRETEXT III, despite normal alpha‐fetoprotein levels (1.28 ng/mL). Tumor rupture necessitated emergency right trisectionectomy and radical colectomy. Histopathology confirmed mixed epithelial‐mesenchymal teratoid hepatoblastoma.
Christine Hyasint Paul   +13 more
wiley   +1 more source

Biliary Abnormality on Imaging During Lenvatinib Plus Hepatic Arterial Infusion Chemotherapy With Cisplatin for Hepatocellular Carcinoma: A Pilot Descriptive Study

open access: yesHepatology Research, Volume 56, Issue 11, Page 1575-1585, November 2026.
ABSTRACT Aim To evaluate the frequency, imaging characteristics, associated factors, and clinical significance of biliary abnormalities on imaging in patients receiving lenvatinib (LEN) plus cisplatin hepatic arterial infusion chemotherapy (HAIC) for hepatocellular carcinoma (HCC).
Hirohito Osanai   +10 more
wiley   +1 more source

Comparison of Uncovered and Covered Biliary SEMS for the Salvage of Obstructed SEMS: A Multicenter Retrospective Propensity Score–Weighted Study

open access: yesJournal of Gastroenterology and Hepatology, Volume 41, Issue 11, Page 3520-3528, November 2026.
In patients undergoing secondary SEMS placement after initial uncovered stent failure, fully covered and uncovered SEMSs showed comparable patency, survival, and safety. However, mechanisms of recurrent biliary obstruction differed by stent type, with tumor ingrowth in uncovered SEMSs and sludge or food impaction in fully covered SEMSs.
Ho Seung Lee   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy